Trial Profile
Effects of Intranasal Administrations of Oxytocin on Behavioural Troubles, Hyperphagia and Social Skills in Children With Prader-Willi Syndrome Aged From 3 to 12 Years.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Oxytocin (Primary)
- Indications Behavioural disorders
- Focus Therapeutic Use
- Acronyms Oxyjeune
- 02 Feb 2019 Status changed from recruiting to completed.
- 18 Apr 2017 New trial record